Sodium hydride → HCID 131730788, Verbindung

HRID 80944

Reaktionsgleichung

Reaktionsgleichung von HRID 80944
[CH:1]([N:4]1[CH2:9][CH2:8][N:7]([C:10]2[N:15]=[N:14][C:13]([C:16]3[CH:21]=[CH:20][C:19]([OH:22])=[CH:18][CH:17]=3)=[CH:12][CH:11]=2)[CH2:6][CH2:5]1)([CH3:3])[CH3:2].[H-].[Na+].[Cl:25][CH2:26][C:27]([N:29]([CH3:31])[CH3:30])=[O:28]>CN(C=O)C>[ClH:25].[ClH:25].[CH:1]([N:4]1[CH2:5][CH2:6][N:7]([C:10]2[N:15]=[N:14][C:13]([C:16]3[CH:17]=[CH:18][C:19]([O:22][CH2:26][C:27]([N:29]([CH3:31])[CH3:30])=[O:28])=[CH:20][CH:21]=3)=[CH:12][CH:11]=2)[CH2:8][CH2:9]1)([CH3:3])[CH3:2]

Komponenten

5

Reaktionsbedingungen

Temperatur
60 °C

Versuchsvorschrift

A mixture of 4-[6-(4-isopropyl-piperazin-1-yl)-pyridazin-3-yl]-phenol (110 mg, 0.37 mmol) and 60% sodium hydride (58 mg, 1.45 mmol) in dry DMF (5 mL) was heated at 60° C. for 30 min. 2-Chloro-N,N-dimethylacetamide (54 mg, 0.44 mmol) was added and heating at 60° C. was continued for another 20 h. The reaction mixture was evaporated to dryness and partitioned between water (10 mL) and DCM (10 mL). The organic phase was isolated, washed with brine (5 mL), dried over anhydrous magnesium sulphate, and evaporated to dryness in vacuo. The residue was dissolved in hot ethyl acetate and HClg in Et2O was added to give the title compound.

Aufarbeitung

  1. temperatureheating at 60° C.
  2. customThe reaction mixture was evaporated to dryness
  3. custompartitioned between water (10 mL) and DCM (10 mL)
  4. customThe organic phase was isolated
  5. washwashed with brine (5 mL)
  6. dry with materialdried over anhydrous magnesium sulphate
  7. customevaporated to dryness in vacuo
  8. dissolutionThe residue was dissolved in hot ethyl acetate
  9. additionHClg in Et2O was added

Quellen und Nachweise

ORD-Eintrag
ord-ad58286448e340c4add39b118395f36f
Quelldatensatz
uspto-grants-2014_09
Patentnummer
US08846677B2

Verknüpfte Notizen

Wird geladen…